WindRose Health Investors recapitalizes Versistat Group pehub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pehub.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, April 7, 2021 /PRNewswire/ WindRose Health Investors, LLC ( WindRose ), a New York City-based healthcare private equity firm, announced the completion of an equity recapitalization of Veristat Group Inc. ( Veristat or the Company ). Veristat is a scientifically minded global clinical research organization (CRO) that empowers biotech and pharmaceutical sponsors to advance complex therapeutic challenges and accelerate innovative therapies. The Company provides essential services along the entire clinical therapeutic development spectrum through regulatory approval and post-approval, including strategic consulting, regulatory affairs, clinical operations, biostatistics, data management, medical writing, and pharmacovigilance. Terms of the transaction were not disclosed.
Veristat Announces New Investment Partner-WindRose Health Investors
Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of Patients Veristat, a scientific-minded, global clinical research organization (CRO), announced today that it transferred its majority ownership from Variance Development Partners to WindRose Health Investors (WindRose). WindRose invests exclusively in healthcare companies and has extensive experience across the healthcare services landscape, including outsourced biopharmaceutical services like Veristat s. As a founder of Veristat, I believe that Veristat has attained the ideal investment partner who understands our philosophy, our values, and the impact we make in clinical research, stated John P. Balser, Ph.D., President, Co-Founder, and Chief Statistical Officer of Veristat. WindRose has a track record of successful collaboration, understands the critical nature of the scientific and therapeutic expertise we
Great Hill Hires Chief People Officer
Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies, has hired
Tracy Keogh to the newly created role of chief people officer, effective May 3. Upon joining Great Hill, Keogh will also become a growth partner. In these roles, Keogh will be responsible for overseeing and scaling all people-focused and human resources initiatives at Great Hill and supporting growth across the firm’s portfolio through strategic talent initiatives.
Keogh joins the firm from
HP Inc., where she held the role of chief human resources officer for over a decade and oversaw the company’s global strategic HR activities and employee communications.
Peak Rock Capital Closes Third Fund At $2B
Peak Rock Capital LLC, a middle-market private investment firm, has closed
Peak Rock Capital Fund III LP and its parallel funds. Fund III substantially its target of $1.3 billion and was over-subscribed, closing at its hard cap on $2.0 billion of limited partner commitments. Peak Rock’s predecessor fund, Fund II, closed on $1.3 billion of commitments in 2017 and its inaugural fund closed on over $700 million in 2013.
Anthony DiSimone, chief executive officer of Peak Rock, said, “The closing of Fund III, at its hard cap, is an endorsement of our team’s ability, through hundreds of transactions and various economic cycles, to significantly grow and fundamentally improve businesses across North America and Europe. We look forward to continuing to work hard for our limited partners and driving further success for all our stakeholders.”